Loading...

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)

RATIONALE: CSF1R tyrosine kinase inhibitors (TKI) and antibodies yield response rates and tumor control in patients with diffuse type tenosynovial giant cell tumors (dTGCT). The long term management of patients with dTGCT treated with TKI is however not known. PATIENTS AND METHODS: We conducted a re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Brahmi, Mehdi, Cassier, Philippe, Dufresne, Armelle, Chabaud, Sylvie, Karanian, Marie, Meurgey, Alexandra, Bouhamama, Amine, Gouin, Francois, Vaz, Gualter, Garret, Jerome, Sunyach, Marie-Pierre, Dupré, Aurélien, Marec-Berard, Perrine, Corradini, Nadège, Perol, David, Ray-Coquard, Isabelle, Blay, Jean-Yves
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239463/
https://ncbi.nlm.nih.gov/pubmed/32433669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233046
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!